Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
MIR4657 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PNPT1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
FITM2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MED13 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
EIF2S1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
LINC01560 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
GEO DataSets Gene Profile neighbors Chromosome neighbors
FBXO28 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
SRPRB - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RBAK - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CHMP2B - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
RAB3GAP2 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MRPL35 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
KPNB1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
AMD1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
MYNN - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
ATF1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
DYRK1A - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
NFYB - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
REEP5 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
CLINT1 - PPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on